Navigation Links
Center for Clinical and Translational Science awards new pilot grants
Date:5/14/2013

rries the virus for life and can pass it on to others. Over the counter treatments can sometimes speed the healing of cold sores, but nothing can block the virus from entering a cell or spreading. Dr. Tibor Valyi-Nagy, associate professor of pathology, in collaboration with Deepak Shukla, associate professor of ophthalmology and visual science, will use their pilot grant to develop ways to block HSV-1 from entering cells or prevent life-long infection.

Iron absorption, obesity, and colorectal cancer

Obesity is a significant risk factor for developing colorectal cancer, the second leading cause of cancer-related death in the U.S., but how obesity and colorectal cancer are linked is poorly understood. Dr. Lisa Tussing-Humphreys, assistant professor of health promotion research in the department of medicine, and her group will investigate the connection between obesity and absorption of iron in the colon and how those factors may trigger colorectal cancer. They will design a clinical trial to examine the effects of dietary iron on the risk of developing colorectal cancer in obesity.

New targets for treating thrombo-inflammatory disease

Platelets and neutrophils are blood components that play a critical role in clotting and in the development of cardiovascular disease. Jaehyung Cho, assistant professor in pharmacology and anesthesiology, and colleagues have identified an enzyme that helps regulate blood factors. They will use their pilot grant to further investigate how the enzyme may influence the formation of dangerous, artery-blocking clots.

A new approach to treating hemophilia

People with hemophilia have defective or missing clotting factors, and for them, even the smallest cut can become a medical emergency. Standard therapy--replacing missing clotting factors--is expensive and can trigger an allergic response. Dr. Xin Huang, assistant professor in the Center for Molecular Biology of Oral D
'/>"/>

Contact: Sharon Parmet
sparmet@uic.edu
312-413-2695
University of Illinois at Chicago
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. New Center for Carbon Measurement to drive UKs low carbon economy
2. Israel names Tel Aviv Universitys Renewable Energy Center a Center of Research Excellence
3. Heart study suggests city center pollution doubles risk of calcium build-up in arteries
4. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
5. UC Santa Cruz builds national data center for cancer genome research
6. UF to establish Faroe Island research center with help of baseball star
7. DOE Plasma Science Center Annual Meeting at Princeton Plasma Lab
8. UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure
9. Tufts Medical Center researchers finds marker in premies saliva predicts readiness to feed by mouth
10. University of Hawaii Cancer Center researchers create new anti-cancer drug
11. Center for North Sea oil expertise set to boost jobs and growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/29/2014)... 2014 — Cambridge, MA and Hebei, China — BGI ... high quality sequencing of the Jujube genome. Jujube is ... and the Jujube genome is particularly difficult to sequence ... factors. It is the first time that a genome ... study has been recently published in Nature ...
(Date:10/28/2014)... of the tragic realities of cancer is that ... toxic and their effectiveness varies unpredictably from patient ... poised to change this reality by rapidly assessing ... an individual,s cancer before chemotherapy begins. , A ... by Assistant Professor Melissa Skala has developed the ...
(Date:10/28/2014)... novel environment are linked to individual differences in ... completed at the University of Eastern Finland and ... study used novel, long-term observations of individual behaviour ... if behaviours predict the vulnerability to fishing in ... rearing environments. Based on the results, it ...
Breaking Biology News(10 mins):BGI Tech and Hebei Agricultural University complete the genome sequencing of the jujube tree 2Improving breast cancer chemo by testing patient's tumors in a dish 2Improving breast cancer chemo by testing patient's tumors in a dish 3Fish 'personality' linked to vulnerability to angling 2
... is the primary component of nursery container substrates in ... widely used organic material is prompting researchers to investigate ... James E. Altland and Charles Krause of the USDA ... Development Center was designed to determine if ground switchgrass ...
... statistics buried within patient records or detailed in newspaper ... patterns, allowing the discovery of trends that were previously ... use of interactive maps and graphs, combined with word ... events like the spread of Swine flu," said Frank ...
... the Braunschweiger Helmholtz-Zentrums fr Infektionsforschung (Helmholtz Center for ... bacterial communities are able to support the degradation ... collaboration of thirteen partners from nine countries. Research ... today at the HZI. The significance of this ...
Cached Biology News:Switchgrass proves viable as nursery container substrate 2Switchgrass proves viable as nursery container substrate 3Visualization of geographic patterns may predict spread of disease 2Improving the degradation of toxic hydrocarbons 2
(Date:10/30/2014)... (PRWEB) October 30, 2014 Spartan Bioscience ... Spartan RX CYP2C19 System . It detects CYP2C19 genetic ... cheek swab. , The Spartan RX CYP2C19 System is ... has been approved in Canada. Due to the system’s ... may be used by healthcare professionals such as doctors, ...
(Date:10/30/2014)... Avure Technologies celebrates a year of success and the one-year ... of high volume High Pressure Processing (HPP) systems. , “We’re ... PackExpo this year, which is where we first announced the ... CEO at Avure. “Sales of the new Avure machine are ... challenges of market demand for higher throughput. We sold our ...
(Date:10/30/2014)... Calif. , Oct. 30, 2014 Isis Pharmaceuticals, ... therapeutics, today announced that management will present a company overview ... at 8:30 a.m. ET in Boston, MA. ... be available on the "Investors & Media" section of the ... on the Isis website within 48 hours and will be ...
(Date:10/30/2014)... , Oct. 30, 2014  Regado Biosciences, Inc. ... will hold a conference call and live audio webcast ... to discuss its third quarter 2014 financial results. ... call by dialing (888) 347-1165 for domestic callers or ... be webcast live under the investor relations section of ...
Breaking Biology Technology:Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Regado Biosciences to Provide Third Quarter 2014 Financial Results 2
... ET, LOS ANGELES, Aug. 31 Signalife, Inc. (Amex:,SGN), Lowell ... update since his matriculation into the Presidency,last month: 1. Dr. ... positions that were producing no revenue whatsoever and no ... Company, in his view. That was done ...
... Aug. 30 Cepheid (Nasdaq:,CPHD) will present at ... the Four Seasons Hotel, Boston, September 5 to ... Senior Vice President, Finance and,Chief Financial Officer, John ... on,September 7. The webcast, along with accompanying ...
... ON, Aug. 30 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: ... oncology company that identifies,develops and commercializes differentiated products ... subsidiary, YM BioSciences USA,Inc. ("YM-USA") has been cleared ... initiate a Phase II trial investigating nimotuzumab in ...
Cached Biology Technology:Signalife Provides Corporate Update 2Signalife Provides Corporate Update 3Cepheid to Present at Thomas Weisel Partners Healthcare Conference 2YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer 2YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer 3YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer 4YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer 5
RABBIT ANTI AMPHOTERIN...
Amino Acid Analysis is performed using ion-exchange separation of the amino acids from acid hydrolysates, followed by ninhydrin detection. Typical quantities required are 0.1 to 0.5 mg, depending on...
... by R. Edwards (1996) • ... types of immunoassays, including RIA, ... and on the photoluminescent and ... information is also given on ...
... contains the basic components required for the ... and recombinant Feline IL-10 in cell culture ... materials to run ELISAs on approximately fifteen ... are met: The assay is run ...
Biology Products: